ADAPTING HEALTH TECHNOLOGY ASSESSMENT AGENCY STANDARDS FOR SURROGATE OUTCOMES IN EARLY STAGE CANCER TRIALS: WHAT NEEDS TO HAPPEN?

January 2024William Dempster (Kristian Thorlund et al.) | Expert Review of Pharmacoeconomics & Outcomes Research